Translating p53-based therapies for cancer into the clinic
Crossref DOI link: https://doi.org/10.1038/s41568-023-00658-3
Published Online: 2024-01-29
Published Print: 2024-03
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Peuget, Sylvain
Zhou, Xiaolei
Selivanova, Galina http://orcid.org/0000-0002-8698-4332
Text and Data Mining valid from 2024-01-29
Version of Record valid from 2024-01-29
Article History
Accepted: 12 December 2023
First Online: 29 January 2024
Competing interests
: G.S. is a co-founder of Aprea Therapeutics AB. All other authors declare no competing interests.